Cathay Biotech Inc. announced that it has received $28,000,000 in a round of funding co-led by Eight Roads Ventures, Sequoia China Investment Management LLP on November 7, 2022. The transaction included participation from returning investors Source Code Capital, Bits x Bites.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.29 CNY | -0.96% | -4.94% | -19.44% |
04-29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.44% | 3.58B | |
+15.04% | 28.31B | |
+11.20% | 1.78B | |
-21.89% | 564M | |
-28.83% | 385M | |
-81.65% | 216M | |
-6.73% | 119M |
- Stock Market
- Equities
- 688065 Stock
- News Cathay Biotech Inc.
- Cathay Biotech Inc. announced that it has received $28 million in funding from Eight Roads Ventures, Sequoia China Investment Management LLP, Source Code Capital, Bits x Bites